NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,000 | -17.4% | 229 | +16.8% | 0.00% | -50.0% |
| Q3 2021 | $23,000 | -32.4% | 196 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $34,000 | +21.4% | 204 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | +27.3% | 204 | +59.4% | 0.00% | 0.0% |
| Q4 2020 | $22,000 | +22.2% | 128 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | +20.0% | 128 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | +15.4% | 128 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -13.3% | 128 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $15,000 | +36.4% | 128 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | +175.0% | 128 | +113.3% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 60 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 60 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -40.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |